株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

脳インプラント市場 - 成長、傾向、および予測(2019年 - 2024年)

Brain Implants Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 871412
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
脳インプラント市場 - 成長、傾向、および予測(2019年 - 2024年) Brain Implants Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 114 Pages
概要

脳インプラント市場の成長の主な要因には、高齢化人口の増加、神経障害の有病率の増加、および機器の技術的進歩等が挙げられます。

当レポートでは世界の脳インプラント市場について調査しており、市場概況や成長要因・阻害要因、製品タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報をまとめています。

目次

第1章 イントロダクション

  • 研究成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 高齢化人口の増加と神経疾患の有病率の増加
    • デバイスの技術的進歩
  • 市場の阻害要因
    • デバイスの高コスト
    • 開発途上地域における低い採用率
  • ポーターファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 製品タイプ別
    • 脳深部刺激装置
    • 脊髄刺激装置
    • 迷走神経刺激装置
  • 用途別
    • 慢性痛
    • てんかん
    • パーキンソン病
    • うつ病
    • 本態性振戦症
    • アルツハイマー病
    • その他の
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東およびアフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott (St Jude Medical)
    • Boston Scientific Corporation
    • LivaNova Plc
    • Medtronic Plc
    • NDI Medical PLC
    • NeuroPace Inc.
    • NeuroSigma
    • Synchron, Inc.
    • Renishaw plc

第7章 市場機会および今後の動向

目次
Product Code: 64161

Market Overview

The major factors for the growth of the brain implants market include the rise in the aging population and an increase in the prevalence of neurological disorders and technological advancements in devices.

The increase in the number of cases of neurological disorders, such as Alzheimer's, epilepsy, Parkinson's, depression, and essential tremors, is anticipated to propel the demand for brain implants. Brain implants are likely to reduce the need for drugs that relieve chronic pain and improve body movement in patients suffering from Parkinson's or any other neurological disease. The growing geriatric population is also prone to more number of neurological disorders. According to the United States Census Bureau's Statistics as of 2017, the total number of people 65 and older exceeds 50 million, and between 2020-2030 the number of the elderly population is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 and older is expected to more than triple from an estimated 6 million today to nearly 20 million by 2060. This influences the growth of the market. However, the growing adoption of brain implants to get quick relief from chronic pain resulting in the high growth of the market.

Scope of the Report

As per the scope of this report, brain implants, are also referred to as neural implants. These are technological devices that connect directly to a biological subject's brain usually placed on the surface of the brain, or attached to the brain's cortex. The market is segmented by product type, application, and geography.

Key Market Trends

Alzheimer's Diseases is expected to be the Fastest Growing Segment Over the Forecast Period

The incidence and prevalence of Alzheimer's have been constantly at a rise and is expected to continue rising in the coming decades. According to a study conducted by the Alzheimer's Association, approximately 476,000 people aged 65 or more in the United States developed Alzheimer's disease in 2016. This suggests that the incidence of Alzheimer's disease has been rising with the increasing years of age. This may have resulted from the increasing geriatric population of the United States, as well as other parts of the world. As reported by the Alzheimer's Society, the number of people with dementia in the United Kingdom increased from 815,827 in 2013 to 856,700 in the year 2015. As per the current trends, the number of people with dementia in the United Kingdom is forecasted to increase to 1,142,677 by 2025 and 2,092,945 by 2051. This suggests a 40% increase over the next 12 years and a 156% increase over the next 38 years. Brain implants may improve cognitive function in people with Alzheimer's disease, which is why Alzheimer's patients prefer brain implant procedures. Hence, the increase in the number of people with Alzheimer's disease is expected to drive the brain implants market during the forecast period.

North America is Expected to Dominate the Market

North America is found to hold a major share for the brain implants market and is expected to show a similar trend over the forecast period, without significant fluctuations. The healthcare facilities in the country are of the highest standards and are accessible to the large population because of favorable policies making healthcare affordable to many, if not all. This helps in gaining higher selling rates across the country. According to the study conducted by the Alzheimer's Association, it is estimated that approximately 63,000 new cases were diagnosed among people in the age group 65 - 74 years. Furthermore, according to Parkinson's Foundation, every year, approximately 60,000 Americans are diagnosed with Parkinson's disease. According to the Center for Disease Control and Prevention, about 1.2% of the total US population had epilepsy in the year 2015. The increase in prevalence and incidence of various neurological disorders indicates a big potential for the market demand for brain implants. The need to diagnose and treat these diseases gives rise to the demand, which may be met by the product manufacturing companies in the country. Because of the favorable factors, the market in the United States is expected to grow at a steady rate in the coming years.

Competitive Landscape

The market studied is consolidated market owing to the presence of a few key players in the market. The major market players are focusing on technological advancement in order to acquire maximum market share. Some of the market players are Abbott (St Jude Medical), Boston Scientific Corporation, LivaNova Plc, Medtronic Plc, NDI Medical PLC, NeuroPace Inc., NeuroSigma, Synchron, Inc., and Renishaw plc

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Aging Population and Increase in Prevalence of Neurological Disorders
    • 4.2.2 Technological Advancements in Devices
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Devices
    • 4.3.2 Low Adoption Rates in Developing and Underdeveloped Regions
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Deep Brain Stimulator
    • 5.1.2 Spinal Cord Stimulator
    • 5.1.3 Vagus Nerve Stimulator
  • 5.2 By Application
    • 5.2.1 Chronic Pain
    • 5.2.2 Epilepsy
    • 5.2.3 Parkinson's Disease
    • 5.2.4 Depression
    • 5.2.5 Essential Tremor
    • 5.2.6 Alzheimer's Disease
    • 5.2.7 Other
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott (St Jude Medical)
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 LivaNova Plc
    • 6.1.4 Medtronic Plc
    • 6.1.5 NDI Medical PLC
    • 6.1.6 NeuroPace Inc.
    • 6.1.7 NeuroSigma
    • 6.1.8 Synchron, Inc.
    • 6.1.9 Renishaw plc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top